
Pubmed-entry ::= {
  pmid 29079360,
  medent {
    em std {
      year 2017,
      month 10,
      day 29,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "PLGA nanoparticles loaded with beta-lactoglobulin-derived
 peptides modulate mucosal immunity and may facilitate cow's milk allergy
 prevention."
      },
      authors {
        names std {
          {
            name ml "Kostadinova AI",
            affil str "Division of Pharmacology, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands; Department of Immunology, Nutricia Research,
 Uppsalalaan 12, 3584CT Utrecht, The Netherlands. Electronic address:
 a.i.kostadinova@uu.nl."
          },
          {
            name ml "Middelburg J",
            affil str "Division of Pharmacology, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands; Division of Pharmaceutics, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands."
          },
          {
            name ml "Ciulla M",
            affil str "Division of Pharmaceutics, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands."
          },
          {
            name ml "Garssen J",
            affil str "Division of Pharmacology, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands; Department of Immunology, Nutricia Research,
 Uppsalalaan 12, 3584CT Utrecht, The Netherlands."
          },
          {
            name ml "Hennink WE",
            affil str "Division of Pharmaceutics, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands."
          },
          {
            name ml "Knippels LMJ",
            affil str "Division of Pharmacology, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands; Department of Immunology, Nutricia Research,
 Uppsalalaan 12, 3584CT Utrecht, The Netherlands."
          },
          {
            name ml "van Nostrum CF",
            affil str "Division of Pharmaceutics, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands."
          },
          {
            name ml "Willemsen LEM",
            affil str "Division of Pharmacology, Utrecht Institute for
 Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG
 Utrecht, The Netherlands."
          }
        }
      },
      from journal {
        title {
          iso-jta "Eur. J. Pharmacol.",
          ml-jta "Eur J Pharmacol",
          issn "1879-0712",
          name "European journal of pharmacology"
        },
        imp {
          date std {
            year 2018,
            month 1,
            day 5
          },
          volume "818",
          pages "211-220",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2017,
                month 7,
                day 20
              }
            },
            {
              pubstatus revised,
              date std {
                year 2017,
                month 10,
                day 22
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2017,
                month 10,
                day 23
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2017,
                month 10,
                day 29,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 8,
                day 7,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2017,
                month 10,
                day 29,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29079360,
        pii "S0014-2999(17)30710-0",
        doi "10.1016/j.ejphar.2017.10.051",
        other {
          db "ELocationID pii",
          tag str "S0014-2999(17)30710-0"
        },
        other {
          db "ELocationID doi",
          tag str "10.1016/j.ejphar.2017.10.051"
        }
      }
    },
    abstract "Beta-lactoglobulin (BLG)-derived peptides may facilitate oral
 tolerance to whey and prevent cow's milk allergy (CMA). Loading of
 BLG-peptides in poly(lactic-co-glycolic acid) (PLGA) nanoparticles (Pep-NP)
 may improve this. Here we studied the uptake of NP and the capacity of NP and
 Pep-NP to activate bone marrow dendritic cells (BMDC). Furthermore, CMA
 prevention was evaluated by orally exposing three-week-old female C3H/HeOuJ
 mice to Pep-NP, NP or free peptides (PepMix) for 6 days before oral
 sensitization with whole whey protein and effects on the spleen and small
 intestine lamina propria (SI-LP) were studied. In BMDC, NP and Pep-NP
 enhanced CD40 expression and IL-6 and TNF-alpha secretion, while tended to
 decrease CD80 expression and prevented PepMix-induced IL-12 secretion. In
 vivo, oral exposure to Pep-NP, but not NP or PepMix, prior to whey
 sensitization tended to partially prevent the acute allergic skin response to
 whole whey protein. Splenocytes of NP-pre-exposed mice secreted increased
 levels of whey-specific IL-6, but this was silenced in Pep-NP-pre-exposed
 mice which also showed reduced TNF-alpha and IFN-gamma secretion. In the
 SI-LP, Pep-NP pre-exposure reduced the CD4(+) T cell frequency in CMA mice
 compared to PBS pre-exposure. In addition, while NP increased whey-specific
 IL-6 secretion in the SI-LP, Pep-NP did not and maintained regulatory
 TGF-beta secretion. This study presents a proof-of-concept that PLGA
 nanoparticles facilitate the capacity of BLG peptides to suppress the
 allergic response to whole whey protein. Hence, PLGA nanoparticles may be
 further developed as an adjunct strategy for BLG-peptide-based oral tolerance
 induction and CMA prevention.",
    mesh {
      {
        term "Allergens",
        qual {
          {
            subh "immunology"
          }
        }
      },
      {
        term "Animals"
      },
      {
        term "Cytokines",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Drug Carriers",
        qual {
          {
            subh "chemistry"
          }
        }
      },
      {
        term "Immunity, Mucosal",
        qual {
          {
            mp TRUE,
            subh "drug effects"
          }
        }
      },
      {
        term "Lactic Acid",
        qual {
          {
            mp TRUE,
            subh "chemistry"
          }
        }
      },
      {
        term "Lactoglobulins",
        qual {
          {
            mp TRUE,
            subh "chemistry"
          }
        }
      },
      {
        term "Mice"
      },
      {
        term "Milk Hypersensitivity",
        qual {
          {
            mp TRUE,
            subh "immunology"
          },
          {
            subh "metabolism"
          },
          {
            mp TRUE,
            subh "prevention & control"
          }
        }
      },
      {
        term "Nanoparticles",
        qual {
          {
            mp TRUE,
            subh "chemistry"
          }
        }
      },
      {
        term "Peptide Fragments",
        qual {
          {
            subh "chemistry"
          },
          {
            mp TRUE,
            subh "pharmacology"
          }
        }
      },
      {
        term "Polyglycolic Acid",
        qual {
          {
            mp TRUE,
            subh "chemistry"
          }
        }
      },
      {
        term "Polylactic Acid-Polyglycolic Acid Copolymer"
      },
      {
        term "Spleen",
        qual {
          {
            subh "drug effects"
          },
          {
            subh "immunology"
          }
        }
      },
      {
        term "T-Lymphocytes, Regulatory",
        qual {
          {
            subh "drug effects"
          },
          {
            subh "immunology"
          }
        }
      },
      {
        term "Whey Proteins",
        qual {
          {
            subh "immunology"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Allergens"
      },
      {
        type nameonly,
        name "Cytokines"
      },
      {
        type nameonly,
        name "Drug Carriers"
      },
      {
        type nameonly,
        name "Lactoglobulins"
      },
      {
        type nameonly,
        name "Peptide Fragments"
      },
      {
        type nameonly,
        name "Whey Proteins"
      },
      {
        type cas,
        cit "1SIA8062RS",
        name "Polylactic Acid-Polyglycolic Acid Copolymer"
      },
      {
        type cas,
        cit "26009-03-0",
        name "Polyglycolic Acid"
      },
      {
        type cas,
        cit "33X04XA5AT",
        name "Lactic Acid"
      }
    },
    pmid 29079360,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}


